TickerFacts.

Tanke Biosciences Corp (TNBI): Cash & Equivalents

Annual figures by period end, from SEC filings.

Not updated since 2012-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

$6.17M
As of 2012-12-31
+50.3%
3-year compound annual growth
$7.70M2009-12-31: $1.82M2010-12-31: $2.22M2011-12-31: $7.70M2012-12-31: $6.17M$6.17M
2009-12-31 Cash & Equivalents (USD) 2012-12-31
Period endedCash & EquivalentsChange YoYSource filing
2012-12-31$6.17M-19.9%2013-04-15, Balance as of period end
2011-12-31$7.70M+246.5%2013-04-15, Balance as of period end
2010-12-31$2.22M+22.2%2012-04-16, Balance as of period end
2009-12-31$1.82Mn/a2012-04-16, Balance as of period end